BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 29635721)

  • 1. Phenotype and genotype of muscle ryanodine receptor rhabdomyolysis-myalgia syndrome.
    Witting N; Laforêt P; Voermans NC; Roux-Buisson N; Bompaire F; Rendu J; Duno M; Feillet F; Kamsteeg EJ; Poulsen NS; Dahlqvist JR; Romero NB; Fauré J; Vissing J; Behin A
    Acta Neurol Scand; 2018 May; 137(5):452-461. PubMed ID: 29635721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RYR1-related rhabdomyolysis: A common but probably underdiagnosed manifestation of skeletal muscle ryanodine receptor dysfunction.
    Voermans NC; Snoeck M; Jungbluth H
    Rev Neurol (Paris); 2016 Oct; 172(10):546-558. PubMed ID: 27663056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in RYR1 are a common cause of exertional myalgia and rhabdomyolysis.
    Dlamini N; Voermans NC; Lillis S; Stewart K; Kamsteeg EJ; Drost G; Quinlivan R; Snoeck M; Norwood F; Radunovic A; Straub V; Roberts M; Vrancken AF; van der Pol WL; de Coo RI; Manzur AY; Yau S; Abbs S; King A; Lammens M; Hopkins PM; Mohammed S; Treves S; Muntoni F; Wraige E; Davis MR; van Engelen B; Jungbluth H
    Neuromuscul Disord; 2013 Jul; 23(7):540-8. PubMed ID: 23628358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The histopathological spectrum of malignant hyperthermia and rhabdomyolysis due to RYR1 mutations.
    Knuiman GJ; Küsters B; Eshuis L; Snoeck M; Lammens M; Heytens L; De Ridder W; Baets J; Scalco RS; Quinlivan R; Holton J; Bodi I; Wraige E; Radunovic A; von Landenberg C; Reimann J; Kamsteeg EJ; Sewry C; Jungbluth H; Voermans NC
    J Neurol; 2019 Apr; 266(4):876-887. PubMed ID: 30788618
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RYR1-Related Rhabdomyolysis: A Spectrum of Hypermetabolic States Due to Ryanodine Receptor Dysfunction.
    Kruijt N; den Bersselaar LV; Snoeck M; Kramers K; Riazi S; Bongers C; Treves S; Jungbluth H; Voermans N
    Curr Pharm Des; 2022; 28(1):2-14. PubMed ID: 34348614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical periodic paralysis and myalgia: A novel
    Matthews E; Neuwirth C; Jaffer F; Scalco RS; Fialho D; Parton M; Raja Rayan D; Suetterlin K; Sud R; Spiegel R; Mein R; Houlden H; Schaefer A; Healy E; Palace J; Quinlivan R; Treves S; Holton JL; Jungbluth H; Hanna MG
    Neurology; 2018 Jan; 90(5):e412-e418. PubMed ID: 29298851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuromuscular symptoms in patients with
    van den Bersselaar LR; Jungbluth H; Kruijt N; Kamsteeg EJ; Fernandez-Garcia MA; Treves S; Riazi S; Malagon I; van Eijk LT; van Alfen N; van Engelen BGM; Scheffer GJ; Snoeck MMJ; Voermans NC
    Brain Commun; 2022; 4(6):fcac292. PubMed ID: 36751502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oral Dantrolene Reduces Myalgia and Hyperckemia in a Child with RYR1-Related Exertional Myalgia/Rhabdomyolysis.
    de Lima Silva EV; Donis KC; Machado FRC; Simão Medeiros L; Aschoff CAM; de Souza CFM; Poswar FO; Saute JAM
    J Neuromuscul Dis; 2023; 10(6):1145-1149. PubMed ID: 37781817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CAV3 mutations causing exercise intolerance, myalgia and rhabdomyolysis: Expanding the phenotypic spectrum of caveolinopathies.
    Scalco RS; Gardiner AR; Pitceathly RD; Hilton-Jones D; Schapira AH; Turner C; Parton M; Desikan M; Barresi R; Marsh J; Manzur AY; Childs AM; Feng L; Murphy E; Lamont PJ; Ravenscroft G; Wallefeld W; Davis MR; Laing NG; Holton JL; Fialho D; Bushby K; Hanna MG; Phadke R; Jungbluth H; Houlden H; Quinlivan R
    Neuromuscul Disord; 2016 Aug; 26(8):504-10. PubMed ID: 27312022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant hyperthermia susceptibility in patients with exertional rhabdomyolysis: a retrospective cohort study and updated systematic review.
    Kraeva N; Sapa A; Dowling JJ; Riazi S
    Can J Anaesth; 2017 Jul; 64(7):736-743. PubMed ID: 28326467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HyperCKemia and rhabdomyolysis in the neuroleptic malignant and serotonin syndromes: A literature review.
    Kruijt N; van den Bersselaar LR; Wijma J; Verbeeck W; Coenen MJH; Neville J; Snoeck M; Kamsteeg EJ; Jungbluth H; Kramers C; Voermans NC
    Neuromuscul Disord; 2020 Dec; 30(12):949-958. PubMed ID: 33250373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RYR1-related myopathies: a wide spectrum of phenotypes throughout life.
    Snoeck M; van Engelen BG; Küsters B; Lammens M; Meijer R; Molenaar JP; Raaphorst J; Verschuuren-Bemelmans CC; Straathof CS; Sie LT; de Coo IF; van der Pol WL; de Visser M; Scheffer H; Treves S; Jungbluth H; Voermans NC; Kamsteeg EJ
    Eur J Neurol; 2015 Jul; 22(7):1094-112. PubMed ID: 25960145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Idiopathic hyperCKemia and malignant hyperthermia susceptibility.
    Santos JM; Andrade PV; Galleni L; Vainzof M; Sobreira CFR; Schmidt B; Oliveira ASB; Amaral JLG; Silva HCA
    Can J Anaesth; 2017 Dec; 64(12):1202-1210. PubMed ID: 28952030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic variation in RYR1 and malignant hyperthermia phenotypes.
    Carpenter D; Robinson RL; Quinnell RJ; Ringrose C; Hogg M; Casson F; Booms P; Iles DE; Halsall PJ; Steele DS; Shaw MA; Hopkins PM
    Br J Anaesth; 2009 Oct; 103(4):538-48. PubMed ID: 19648156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recurrent rhabdomyolysis due to muscle β-enolase deficiency: very rare or underestimated?
    Musumeci O; Brady S; Rodolico C; Ciranni A; Montagnese F; Aguennouz M; Kirk R; Allen E; Godfrey R; Romeo S; Murphy E; Rahman S; Quinlivan R; Toscano A
    J Neurol; 2014 Dec; 261(12):2424-8. PubMed ID: 25267339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rhabdomyolysis and fluctuating asymptomatic hyperCKemia associated with CACNA1S variant.
    Anandan C; Cipriani MA; Laughlin RS; Niu Z; Milone M
    Eur J Neurol; 2018 Feb; 25(2):417-419. PubMed ID: 29193480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel ANO5 homozygous microdeletion causing myalgia and unprovoked rhabdomyolysis in an Arabic man.
    Lahoria R; Winder TL; Lui J; Al-Owain MA; Milone M
    Muscle Nerve; 2014 Oct; 50(4):610-3. PubMed ID: 24889862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal myosin post-translational modifications and ATP turnover time associated with human congenital myopathy-related RYR1 mutations.
    Sonne A; Antonovic AK; Melhedegaard E; Akter F; Andersen JL; Jungbluth H; Witting N; Vissing J; Zanoteli E; Fornili A; Ochala J
    Acta Physiol (Oxf); 2023 Oct; 239(2):e14035. PubMed ID: 37602753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An unusual ryanodine receptor 1 (RYR1) phenotype: Mild calf-predominant myopathy.
    Jokela M; Tasca G; Vihola A; Mercuri E; Jonson PH; Lehtinen S; Välipakka S; Pane M; Donati M; Johari M; Savarese M; Huovinen S; Isohanni P; Palmio J; Hartikainen P; Udd B
    Neurology; 2019 Apr; 92(14):e1600-e1609. PubMed ID: 30842289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RYR1 mutations causing central core disease are associated with more severe malignant hyperthermia in vitro contracture test phenotypes.
    Robinson RL; Brooks C; Brown SL; Ellis FR; Halsall PJ; Quinnell RJ; Shaw MA; Hopkins PM
    Hum Mutat; 2002 Aug; 20(2):88-97. PubMed ID: 12124989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.